glucose, (beta-d)-isomer has been researched along with alpha-synuclein in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 12 (66.67) | 24.3611 |
| 2020's | 6 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, YB; Hu, LF; Li, J; Liu, CF; Sun, X; Wang, F; Yang, YP | 1 |
| Kamitani, T; Matsuo, Y; Usuki, S; Yu, RK | 1 |
| Gadad, BS; Pullabhatla, S; Rao, KS; Shantharam, IS; Subramanya, PK | 1 |
| Li, L; Li, Y; Xing, Y; Yu, S; Zhang, L; Zhang, R | 1 |
| Deng, Z; Pu, X; Sun, Y; Zhao, X; Zhou, J | 1 |
| Dikiy, I; Eliezer, D | 1 |
| Li, L; Li, YL; Shen, C; Sun, FL; Zhang, L; Zhang, RY | 1 |
| He, X; Ren, J; Wang, Y; Yuan, J; Zhao, Y | 1 |
| Brites, D; Brito, MA; Kim, KS; Palmela, I; Pirc, K; Pogačnik, L; Silva, RF; Skrt, M; Ulrih, NP | 1 |
| Cai, F; Chen, S; Gu, C; Mao, G; Wang, G; Wang, J; Yan, J; Yang, Z | 1 |
| Cao, X; Li, Z; Yan, J; Yang, Z; Zhao, N | 1 |
| Fan, Y; Jian, W; Liu, C; Shi, D; Zheng, M | 1 |
| Barletta, E; Bucciantini, M; Degl'Innocenti, D; Leri, M; Nielsen, E; Palazzi, L; Vasarri, M | 1 |
| Aibaidula, Y; Aimaiti, M; Aisa, Y; Chen, Q; Feng, X; Lei, X; Mi, N; Wumaier, A; Xirepu, X; Zhang, Y | 1 |
| Guo, K; Jin, M; Li, L; Liu, D; Luo, N; Rong, H; Wang, J; Zhang, J; Zhang, X; Zhang, Y | 1 |
| Abdelraouf, SM; Al-Kady, RH; Motawi, TK; Senousy, MA | 1 |
| Elyasi, L; Jahanshahi, M; Jesmi, F; Rosenholm, JM | 1 |
| Dong, HY; Jin, M; Li, HY; Li, LB; Liu, DS; Luo, N; Rong, H; Wang, JP; Zhang, JY; Zhang, XJ; Zhang, YB | 1 |
1 review(s) available for glucose, (beta-d)-isomer and alpha-synuclein
| Article | Year |
|---|---|
The Antioxidative Effects of Picein and Its Neuroprotective Potential: A Review of the Literature.
Topics: alpha-Synuclein; Animals; Antioxidants; Curcumin; Glucosides; Neurodegenerative Diseases; Neuroprotective Agents; Panax; Resveratrol; tau Proteins; Withania | 2022 |
17 other study(ies) available for glucose, (beta-d)-isomer and alpha-synuclein
| Article | Year |
|---|---|
ASICs mediate the modulatory effect by paeoniflorin on α-synuclein autophagic degradation.
Topics: 1-Methyl-4-phenylpyridinium; Acid Sensing Ion Channels; Acidosis; alpha-Synuclein; Animals; Anti-Inflammatory Agents, Non-Steroidal; Autophagy; Benzoates; Bridged-Ring Compounds; Cytoprotection; Glucosides; Microtubule-Associated Proteins; Monoterpenes; Nerve Tissue Proteins; Neurons; Parkinson Disease; PC12 Cells; Rats; Sodium Channels; Vacuoles | 2011 |
Pathobiochemical effect of acylated steryl-β-glucoside on aggregation and cytotoxicity of α-synuclein.
Topics: Adenosine Triphosphate; alpha-Synuclein; Amyotrophic Lateral Sclerosis; Cycas; Dementia; Glucosides; Humans; Neurotoxins; Parkinsonian Disorders; Proteostasis Deficiencies; Seeds; Unilamellar Liposomes | 2012 |
Curcumin-glucoside, a novel synthetic derivative of curcumin, inhibits α-synuclein oligomer formation: relevance to Parkinson's disease.
Topics: alpha-Synuclein; Calorimetry; Curcumin; Dose-Response Relationship, Drug; Drug Design; Glucosides; Parkinson Disease; Protein Binding; Protein Multimerization; Solubility | 2012 |
Tetrahydroxystilbene glucoside antagonizes age-related α-synuclein overexpression in the hippocampus of APP transgenic mouse model of Alzheimer's disease.
Topics: Aging; alpha-Synuclein; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Blotting, Western; Brain Chemistry; Data Interpretation, Statistical; DNA, Complementary; Glucosides; Hippocampus; Humans; Immunohistochemistry; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microarray Analysis; Nootropic Agents; Real-Time Polymerase Chain Reaction; RNA, Messenger; Stilbenes | 2013 |
3-O-demethylswertipunicoside inhibits MPP⁺-induced oxidative stress and apoptosis in PC12 cells.
Topics: 1-Methyl-4-phenylpyridinium; alpha-Synuclein; Animals; Apoptosis; Apoptosis Inducing Factor; bcl-2-Associated X Protein; Blotting, Western; Dopamine Agents; Glucosides; Malondialdehyde; Mitochondria; Neuroprotective Agents; Oxidative Stress; PC12 Cells; Protein Transport; Proto-Oncogene Proteins c-bcl-2; Rats; Reactive Oxygen Species; Signal Transduction; Superoxide Dismutase; Xanthones | 2013 |
N-terminal acetylation stabilizes N-terminal helicity in lipid- and micelle-bound α-synuclein and increases its affinity for physiological membranes.
Topics: Acetylation; alpha-Synuclein; Glucosides; Humans; Membranes, Artificial; Micelles; Models, Molecular; Protein Stability; Protein Structure, Secondary; Sodium Dodecyl Sulfate | 2014 |
Tetrahydroxystilbene glucoside ameliorates memory and movement functions, protects synapses and inhibits α-synuclein aggregation in hippocampus and striatum in aged mice.
Topics: Aging; alpha-Synuclein; Animals; Avoidance Learning; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cerebral Cortex; Corpus Striatum; Female; Glucosides; Hippocampus; Memory; Memory Disorders; Mice, Inbred C57BL; Motor Activity; Movement Disorders; Neuroprotective Agents; Nootropic Agents; Protein Aggregates; Stilbenes; Synapses; Treatment Outcome | 2015 |
Acteoside Binds to Caspase-3 and Exerts Neuroprotection in the Rotenone Rat Model of Parkinson's Disease.
Topics: alpha-Synuclein; Animals; Caspase 3; Disease Models, Animal; Glucosides; Humans; Microtubule-Associated Proteins; Molecular Dynamics Simulation; Parkinson Disease; Phenols; Protein Binding; Rats; Rats, Sprague-Dawley; Rotenone | 2016 |
Potential for brain accessibility and analysis of stability of selected flavonoids in relation to neuroprotection in vitro.
Topics: alpha-Synuclein; Animals; Anthocyanins; Antioxidants; Apoptosis; Brain; Catechin; Cells, Cultured; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Stability; Endothelial Cells; Flavonoids; Glucosides; Humans; Necrosis; Neurons; Neuroprotective Agents; Oxidative Stress; Protein Multimerization; Quercetin; Rats, Wistar; Recombinant Proteins | 2016 |
Salidroside protects SH‑SY5Y from pathogenic α‑synuclein by promoting cell autophagy via mediation of mTOR/p70S6K signaling.
Topics: alpha-Synuclein; Autophagy; Cell Line; Glucosides; Humans; Neuroprotective Agents; Parkinson Disease; Phenols; Point Mutation; Rhodiola; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; TOR Serine-Threonine Kinases | 2019 |
Gastrodin protects dopaminergic neurons via insulin-like pathway in a Parkinson's disease model.
Topics: alpha-Synuclein; Animals; Animals, Genetically Modified; Benzyl Alcohols; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Chemotaxis; Dopaminergic Neurons; Dose-Response Relationship, Drug; Forkhead Transcription Factors; Glucosides; Neuroprotection; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Receptor, Insulin; Signal Transduction | 2019 |
Total glucosides of paeony (TGP) extracted from Radix Paeoniae Alba exerts neuroprotective effects in MPTP-induced experimental parkinsonism by regulating the cAMP/PKA/CREB signaling pathway.
Topics: alpha-Synuclein; Animals; Corpus Striatum; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Dopamine; Glucosides; Homovanillic Acid; Male; Mice, Inbred C57BL; Motor Activity; MPTP Poisoning; Neuroprotective Agents; Paeonia; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Substantia Nigra | 2019 |
Maysin plays a protective role against α-Synuclein oligomers cytotoxicity by triggering autophagy activation.
Topics: alpha-Synuclein; Autophagy; Biopolymers; Cell Death; Cell Line; Flavonoids; Glucosides; Humans; Oxidative Stress | 2020 |
Acteoside exerts neuroprotection effects in the model of Parkinson's disease via inducing autophagy: Network pharmacology and experimental study.
Topics: Adenylate Kinase; alpha-Synuclein; Animals; Apoptosis; Autophagy; Cell Line, Tumor; Cell Survival; Computational Biology; Drosophila melanogaster; Glucosides; HEK293 Cells; Humans; Longevity; Membrane Potential, Mitochondrial; Models, Biological; Motor Activity; Neurons; Neuroprotective Agents; Parkinson Disease; Phenols; Rats; Reactive Oxygen Species; Rotenone | 2021 |
Neuroprotective effect of paeoniflorin in the mouse model of Parkinson's disease through α-synuclein/protein kinase C δ subtype signaling pathway.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Synuclein; Animals; Annexin A5; Anti-Inflammatory Agents, Non-Steroidal; Antiparkinson Agents; Apoptosis; Disease Models, Animal; Glucosides; Mice; Microscopy, Electron, Transmission; Monoterpenes; Neurotoxins; Parkinsonian Disorders; Protein Kinase C-delta; Rotarod Performance Test; Selegiline; Substantia Nigra | 2021 |
Empagliflozin alleviates endoplasmic reticulum stress and augments autophagy in rotenone-induced Parkinson's disease in rats: Targeting the GRP78/PERK/eIF2α/CHOP pathway and miR-211-5p.
Topics: alpha-Synuclein; Animals; Apoptosis; Autophagy; Beclin-1; Benzhydryl Compounds; Catalase; eIF-2 Kinase; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Eukaryotic Initiation Factor-2; Glucosides; Heat-Shock Proteins; MicroRNAs; Parkinson Disease; Rats; Rotenone; Transcription Factor CHOP | 2022 |
Total Glucosides of White Paeony Capsule ameliorates Parkinson's disease-like behavior in MPTP-induced mice model by regulating LRRK2/alpha-synuclein signaling.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Synuclein; Animals; Disease Models, Animal; Dopaminergic Neurons; Glucosides; Mice; Mice, Inbred C57BL; Neuroinflammatory Diseases; Neuroprotective Agents; Paeonia; Parkinson Disease | 2024 |